Deerfield Management Company, L.P. (Series C) Lantheus Holdings, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 240,218 shares of LNTH stock, worth $18.5 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
240,218
Previous 240,218
-0.0%
Holding current value
$18.5 Million
Previous $19.3 Million
36.69%
% of portfolio
0.49%
Previous 0.4%
Shares
2 transactions
Others Institutions Holding LNTH
# of Institutions
538Shares Held
68.3MCall Options Held
679KPut Options Held
423K-
Black Rock Inc. New York, NY8.6MShares$660 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.42MShares$570 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$276 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.96MShares$227 Million1.63% of portfolio
-
State Street Corp Boston, MA2.52MShares$194 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $5.28B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...